PYCR1 and cancer: In our NF and CAF models, however, we could not find consistent differences in glucose and glutamine usage, and targeting PYCR1 in CAFs resulted in reduced collagen in the stroma of tumour xenografts and in 2D and 3D cocultures with cancer cells.